● Recruiting

Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients

Condition: Acute Myeloblastic Leukemia · Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace

PhaseNA

Planned participants30

Who can joinAll sexes, 60 Years to no upper limit

Healthy volunteersYes

About this study

The main objective of this study is to identify epigenetic markers specific to abnormal myeloid cells in patients with acute myeloid leukemia (AML) by analyzing the methylation of circulating cell-free DNA in plasma.

This description comes directly from the study's public registry record.

Talk to the study team

Bernard DRENOU, Dr · +33389646464 · drenoub@ghrmsa.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Groupe Hospitalier de la Région de Mulhouse et Sud Alsace	Mulhouse, Alsace, France	Recruiting
GHRMSA	Mulhouse, France	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07250217